Literature DB >> 24332368

SMN is essential for the biogenesis of U7 small nuclear ribonucleoprotein and 3'-end formation of histone mRNAs.

Sarah Tisdale1, Francesco Lotti1, Luciano Saieva1, James P Van Meerbeke2, Thomas O Crawford3, Charlotte J Sumner4, George Z Mentis1, Livio Pellizzoni5.   

Abstract

Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by a deficiency in the survival motor neuron (SMN) protein. SMN mediates the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs) and possibly other RNPs. Here, we investigated SMN requirement for the biogenesis and function of U7--an snRNP specialized in the 3'-end formation of replication-dependent histone mRNAs that normally are not polyadenylated. We show that SMN deficiency impairs U7 snRNP assembly and decreases U7 levels in mammalian cells. The SMN-dependent U7 reduction affects endonucleolytic cleavage of histone mRNAs leading to abnormal accumulation of 3'-extended and polyadenylated transcripts followed by downstream changes in histone gene expression. Importantly, SMN deficiency induces defects of histone mRNA 3'-end formation in both SMA mice and human patients. These findings demonstrate that SMN is essential for U7 biogenesis and histone mRNA processing in vivo and identify an additional RNA pathway disrupted in SMA.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24332368      PMCID: PMC3885245          DOI: 10.1016/j.celrep.2013.11.012

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  34 in total

1.  SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.

Authors:  Thomas M Wishart; Jack P-W Huang; Lyndsay M Murray; Douglas J Lamont; Chantal A Mutsaers; Jenny Ross; Pascal Geldsetzer; Olaf Ansorge; Kevin Talbot; Simon H Parson; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2010-08-12       Impact factor: 6.150

2.  Efficient oligonucleotide-mediated degradation of nuclear noncoding RNAs in mammalian cultured cells.

Authors:  Takashi Ideue; Kimihiro Hino; Saori Kitao; Takahide Yokoi; Tetsuro Hirose
Journal:  RNA       Date:  2009-06-17       Impact factor: 4.942

Review 3.  Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail.

Authors:  William F Marzluff; Eric J Wagner; Robert J Duronio
Journal:  Nat Rev Genet       Date:  2008-11       Impact factor: 53.242

Review 4.  Roles of eukaryotic Lsm proteins in the regulation of mRNA function.

Authors:  Sundaresan Tharun
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 5.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

6.  Knockdown of SLBP results in nuclear retention of histone mRNA.

Authors:  Kelly D Sullivan; Thomas E Mullen; William F Marzluff; Eric J Wagner
Journal:  RNA       Date:  2009-01-20       Impact factor: 4.942

Review 7.  GammaH2AX and cancer.

Authors:  William M Bonner; Christophe E Redon; Jennifer S Dickey; Asako J Nakamura; Olga A Sedelnikova; Stéphanie Solier; Yves Pommier
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

8.  Gemin5 delivers snRNA precursors to the SMN complex for snRNP biogenesis.

Authors:  Jeongsik Yong; Mumtaz Kasim; Jennifer L Bachorik; Lili Wan; Gideon Dreyfuss
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

9.  Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs.

Authors:  Francesca Gabanella; Matthew E R Butchbach; Luciano Saieva; Claudia Carissimi; Arthur H M Burghes; Livio Pellizzoni
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

10.  SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing.

Authors:  Zhenxi Zhang; Francesco Lotti; Kimberly Dittmar; Ihab Younis; Lili Wan; Mumtaz Kasim; Gideon Dreyfuss
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

View more
  33 in total

1.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

Review 2.  Developing therapies for spinal muscular atrophy.

Authors:  Mary H Wertz; Mustafa Sahin
Journal:  Ann N Y Acad Sci       Date:  2015-07-14       Impact factor: 5.691

Review 3.  Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Authors:  Sarah Tisdale; Livio Pellizzoni
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

Review 4.  SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease.

Authors:  Darrick K Li; Sarah Tisdale; Francesco Lotti; Livio Pellizzoni
Journal:  Semin Cell Dev Biol       Date:  2014-04-24       Impact factor: 7.727

Review 5.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

6.  Conditional deletion of SMN in cell culture identifies functional SMN alleles.

Authors:  Anton J Blatnik; Vicki L McGovern; Thanh T Le; Chitra C Iyer; Brian K Kaspar; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-10-19       Impact factor: 6.150

7.  Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy.

Authors:  Kevin A Kaifer; Eric Villalón; Erkan Y Osman; Jacqueline J Glascock; Laura L Arnold; D D W Cornelison; Christian L Lorson
Journal:  JCI Insight       Date:  2017-03-09

8.  CBP-mediated SMN acetylation modulates Cajal body biogenesis and the cytoplasmic targeting of SMN.

Authors:  Vanesa Lafarga; Olga Tapia; Sahil Sharma; Rocio Bengoechea; Georg Stoecklin; Miguel Lafarga; Maria T Berciano
Journal:  Cell Mol Life Sci       Date:  2017-09-06       Impact factor: 9.261

9.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

Review 10.  Spinal muscular atrophy: journeying from bench to bedside.

Authors:  Tomoyuki Awano; Jeong-Ki Kim; Umrao R Monani
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.